GNL3L and metastatic malignant neoplasm in the lymph nodes: Analyses through the TCGA melanoma data set supported an increased mRNA expression of DDX3X, EIF1AC, GNL3L, and RBMX in skin or lymph node metastases, but with no significant correlation with overall patient survival (Supplementary Table 2).